Skip to main content
. 2014 Feb 11;136(9):3664–3672. doi: 10.1021/ja500053x

Table 2. Pharmacokinetic Parameters of Oxadiazolesa.

cmpd dose (mg/kg) AUC0–∞ (μg·min/mL) Cmax (μg/mL) Tmax (h) CL (mL/min/kg) Vd (mL/kg) t1/2 F (%)
2 50 iv 1380     36.2 860 t1/2α = 2.4 min  
t1/2β = 4.4 h
3 50 iv 2650     18.9 370 t1/2α = 3.5 min  
t1/2β = 22 h
  50 po 2620 2.5 2     t1/2abs = 3.3 h ∼100
t1/2dist = 6.0 h
t1/2elim = 40 h
4 50 iv 9200     5.4 720 t1/2α = 6.7 min  
t1/2β = 20 h
  50 po 9220 10.0 2     t1/2abs = 2.4 h 100
t1/2dist = 13 h
t1/2elim = 36 h
a

n = 3 mice per time point per route of administration; 10–12 time points. AUC0–∞, area under the plasma concentration–time curve from 0 to infinity; Cmax, maximum concentration observed in plasma; Tmax, time at which maximum plasma concentration is observed; CL, plasma clearance; Vd, volume of distribution; t1/2α, initial half-life; t1/2β, terminal half-life; t1/2abs, absorption half-life; t1/2dist, distribution half-life; t1/2elim, elimination half-life; F, oral bioavailability.